Alimera Sciences, Inc. (ALIM)의 가격은 얼마입니까?

Alimera Sciences, Inc. (ALIM)의 가격은 $5.54입니다.

Alimera Sciences, Inc. (ALIM)의 시가 총액은 무엇입니까?

Alimera Sciences, Inc. (ALIM)의 시가 총액은 $38.76M입니다.

Alimera Sciences, Inc. (ALIM) 수익

Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.

연도	수익	변화
2026 (TTM)	$-14.71M	-26.61%
2023	$-20.05M	10.89%
2022	$-18.08M	359.56%
2021	$-3.93M	-27.24%
2020	$-5.41M	-47.13%
2019	$-10.23M	-37.17%
2018	$-16.28M	-25.47%
2017	$-21.84M	-33.83%
2016	$-33.00M	8.15%
2015	$-30.52M	-14.61%
2014	$-35.74M	-22.70%
2013	$-46.23M	134.12%
2012	$-19.75M	-12.30%
2011	$-22.52M	32.74%
2010	$-16.96M	-59.95%
2009	$-42.36M	-30.03%
2008	$-60.54M	383.70%
2007	$-12.52M	20.64%
2006	$-10.37M	0.00%

연도

수익

변화

2026 (TTM)

$-14.71M

-26.61%

2023

$-20.05M

10.89%

2022

$-18.08M

359.56%

2021

$-3.93M

-27.24%

2020

$-5.41M

-47.13%

2019

$-10.23M

-37.17%

2018

$-16.28M

-25.47%

2017

$-21.84M

-33.83%

2016

$-33.00M

8.15%

2015

$-30.52M

-14.61%

2014

$-35.74M

-22.70%

2013

$-46.23M

134.12%

2012

$-19.75M

-12.30%

2011

$-22.52M

32.74%

2010

$-16.96M

-59.95%

2009

$-42.36M

-30.03%

2008

$-60.54M

383.70%

2007

$-12.52M

20.64%

2006

$-10.37M

0.00%

회사	수익	수익 차이	국가
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$1.76B	-12,093.96%	IN

회사

수익

수익 차이

국가